228 related articles for article (PubMed ID: 18791689)
1. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.
Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
Clin Exp Med; 2008 Sep; 8(3):159-64. PubMed ID: 18791689
[TBL] [Abstract][Full Text] [Related]
2. Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
Ekelund C; Dereke J; Nilsson C; Landin-Olsson M
PLoS One; 2024; 19(6):e0304173. PubMed ID: 38843125
[TBL] [Abstract][Full Text] [Related]
3. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration.
Olson JA; Whitelaw CM; McHardy KC; Pearson DW; Forrester JV
Diabetologia; 1997 Oct; 40(10):1166-71. PubMed ID: 9349597
[TBL] [Abstract][Full Text] [Related]
4. Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients.
Boulbou MS; Koukoulis GN; Petinaki EA; Germenis A; Gourgoulianis KI
Acta Diabetol; 2004 Sep; 41(3):118-22. PubMed ID: 15666579
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy.
Clausen P; Jacobsen P; Rossing K; Jensen JS; Parving HH; Feldt-Rasmussen B
Diabet Med; 2000 Sep; 17(9):644-9. PubMed ID: 11051283
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.
McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
J Neurol; 1999 Feb; 246(2):87-92. PubMed ID: 10195402
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
9. Soluble endothelium-associated adhesion molecules in patients with Graves' disease.
Wenisch C; Myskiw D; Parschalk B; Hartmann T; Dam K; Graninger W
Clin Exp Immunol; 1994 Nov; 98(2):240-4. PubMed ID: 7525128
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
11. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
[TBL] [Abstract][Full Text] [Related]
12. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
13. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
[TBL] [Abstract][Full Text] [Related]
14. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations.
Miles EA; Thies F; Wallace FA; Powell JR; Hurst TL; Newsholme EA; Calder PC
Clin Sci (Lond); 2001 Jan; 100(1):91-100. PubMed ID: 11115423
[TBL] [Abstract][Full Text] [Related]
15. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
16. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients.
Boldt J; Muller M; Kuhn D; Linke LC; Hempelmann G
Intensive Care Med; 1996 Feb; 22(2):122-8. PubMed ID: 8857119
[TBL] [Abstract][Full Text] [Related]
17. Circulating adhesion molecules in pediatric cardiac surgery.
Boldt J; Osmer C; Linke LC; Dapper F; Hempelmann G
Anesth Analg; 1995 Dec; 81(6):1129-35. PubMed ID: 7486093
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecule profiling in preoperative infants with biliary atresia.
Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM
J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350
[TBL] [Abstract][Full Text] [Related]
19. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment.
Kowalzick L; Kleinheinz A; Neuber K; Weichenthal M; Köhler I; Ring J
Dermatology; 1995; 190(1):14-8. PubMed ID: 7534511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
